Inotiv, Inc. Expands Protein/Peptide Bioanalytical Capabilities with Acquisition of Protypia, Inc.
July 07, 2022 16:05 ET
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., July 07, 2022 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...
Inotiv, Inc. Announces Expansion of Safety Assessment Offerings with Acquisition of Integrated Laboratory Systems, LLC
January 10, 2022 08:33 ET
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...
Inotiv, Inc. Announces Opening of Newly-Constructed Laboratories at St. Louis Facility
November 10, 2021 08:33 ET
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., Nov. 10, 2021 (GLOBE NEWSWIRE) -- November 10, 2021 -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization...
BASi Names John E. Sagartz Chief Strategy Officer
November 01, 2018 08:43 ET
|
Bioanalytical Systems, Inc.
WEST LAFAYETTE, Ind., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi” or the “Company”) today announced the appointment of John E. Sagartz, DVM, PhD, DACVP, as...
BASi Announces Appointment of John E. Sagartz to Board of Directors
July 09, 2018 09:00 ET
|
Bioanalytical Systems, Inc.
WEST LAFAYETTE, Ind., July 09, 2018 (GLOBE NEWSWIRE) -- Bioanalytical Systems, Inc. (NASDAQ:BASI) has announced that its Board of Directors agreed unanimously on July 2, 2018, to appoint John E....